BEAMSTART Logo

Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug

Business Standard LogoBusiness Standard1d ago

Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug - Business Standard

Quick Summary:

Indoco Remedies share price surged 5.42 per cent at Rs 317.

Its shares are trading at a price to earnings multiple of 26.30 times and at an earning per share of Rs 11.46.

In March 2023, IQVIA MAT reported that the yearly sales for Varenicline Tablets were $501 million in the US.


More Pictures

Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-30 @ 12:03:04 (1 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 366 words

Reading Time: 3 minutes read

Sentences: 17 lines

Sentence Length: 22 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23335549

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 231 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug" has 366 words across 17 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Which news outlet covered this story?

The story "Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug" was covered 1 days ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 231 news stories per day.

It's most recent story was published 3 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #23335549
  • URL: https://beamstart.com/news/indoco-remedies-zooms-5-after-17302705547926

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.